Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma
T. Hinks (Oxford, United Kingdom), B. Hilvering (Utrecht, Netherlands), L. Stoger (Oxford, United Kingdom), E. Marchi (Oxford, United Kingdom), M. Salimi (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), W. Lu (Oxford, United Kingdom), W. Chen (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), S. Go (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), S. Thulborn (Oxford, United Kingdom), A. Kurioka (Oxford, United Kingdom), T. Leng (Oxford, United Kingdom), J. Matthews (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom), C. Willberg (Oxford, United Kingdom), A. Ramasamy (Oxford, United Kingdom), R. Djukanovic (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom)
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Disease area: Airway diseases
Abstract Background : Severe asthma with persistent airway eosinophilia despite high-intensity inhaled corticosteroids is a phenotype associated with high exacerbation risk. A major barrier to progress is poor understanding of the pathogenic mechanisms and cell types contributing to the disease.
Aims and objectives: To determine the function of type-2 cytokine producing CD8+ T cells in severe eosinophilic asthma, and investigate their contribution to pathogenesis of the disease.
Methods : Profiles of type-2 CD8+ T cells (Tc2) and type-2 T helper (Th2), in different asthma phenotypes were analysed with flow cytometry. Tc2 cells were isolated and cultured in vitro. Effects of prostaglandin D2 (PGD2) and leukotriene E4 (LTE4) on Tc2 cells were defined using chemotaxis assays, Luminex, quantitative RT-PCR, PrimeFlow RNA assay and microarray. Effects of Tc2 supernatants were determined on eosinophil shape change and apoptosis, and on eosinophil chemokine production from airway epithelial cells.
Results : In two independent patient cohorts we show that, in contrast to Th2 cells, type-2 cytokine-secreting CD8+CRTH2+ Tc2 cells are enriched in blood and airways, and concentrations of prostaglandin D2 (PGD2) and cysteinyl leukotriene E4 (LTE4) are also increased in the airways in severe eosinophilic asthma. In vitro PGD2 and LTE4 function synergistically to enhance Tc2 cell recruitment and activation. They regulate diverse genes in Tc2 cells inducing type-2 cytokines and many other pro-inflammatory cytokines and chemokines which could contribute to eosinophilia.
Conclusions : These finding are consistent with an important role for human Tc2 cells in severe eosinophilic asthma.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Hinks (Oxford, United Kingdom), B. Hilvering (Utrecht, Netherlands), L. Stoger (Oxford, United Kingdom), E. Marchi (Oxford, United Kingdom), M. Salimi (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), W. Lu (Oxford, United Kingdom), W. Chen (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), S. Go (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), J. Cane (Oxford, United Kingdom), S. Thulborn (Oxford, United Kingdom), A. Kurioka (Oxford, United Kingdom), T. Leng (Oxford, United Kingdom), J. Matthews (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom), C. Willberg (Oxford, United Kingdom), A. Ramasamy (Oxford, United Kingdom), R. Djukanovic (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom). Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma. 4927
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 25s Year: 2005
CD8+ Tc2 cells: underappreciated contributors to severe asthma Source: Eur Respir Rev, 28 (154) 190092; 10.1183/16000617.0092-2019 Year: 2019
High percentage of CD8+ effector T lymphocytes in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002
CD4+ and CD8+ T lymphocytes display a Th2/Tc2 cytokine profile in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004
CD4+CD25+ T lymphocytes in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004
Increased T helper lymphocytes and macrophages in peripheral airways of patients with uncontrolled asthma Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010
IL-10-producing CD4+ T cells are essential for the development of airway hyperresponsiveness Source: Annual Congress 2004 - Modulation of the allergic response in animal models Year: 2004
Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010
The declined CD4+ CD25+Treg cells in patients with moderate to severe asthma associated with over-expressed Th2 response Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012
Characteristics of fatal asthma: CD8 positive T cells producing IFN-γ and IL-18 were recruited into small airways in fatal asthma Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
Increase of both blood CXCR3+ and CCR4+ helper T cells associated with severity of asthma Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005
CMV- and EBV-specific CD8+ T cell responses in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
PAS-1, an Ascaris suum protein, modulates allergic airway inflammation via CD8+ and CD4+ CD25+ T cells Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018
Reduced numbers of circulating CD4+ CD25high FOXP3+ regulatory T cells in patients with allergic asthma Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008
Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking Source: Eur Respir J 2007; 29: 42-50 Year: 2007
LATE-BREAKING ABSTRACT: Increased cytotoxic T cells, CX3CR1+, γδ and IL17+ T cells in severe asthma during exacerbation Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments Year: 2012
Late-breaking abstract: Role of IL-13-producing BLT1-positive CD8 T cells in asthmatic airway obstruction Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011
Airway granzyme B from CD8+ T-cells is related to severity of airflow obstruction in smokers Source: Eur Respir J 2006; 28: Suppl. 50, 673s Year: 2006